Logo image of JEN.BR

JENSEN-GROUP NV (JEN.BR) Stock Fundamental Analysis

Europe - EBR:JEN - BE0003858751 - Common Stock

62.8 EUR
-0.4 (-0.63%)
Last: 9/16/2025, 7:00:00 PM
Fundamental Rating

7

JEN gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 103 industry peers in the Machinery industry. JEN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. JEN may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make JEN suitable for value investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year JEN was profitable.
In the past year JEN had a positive cash flow from operations.
JEN had positive earnings in each of the past 5 years.
Of the past 5 years JEN 4 years had a positive operating cash flow.
JEN.BR Yearly Net Income VS EBIT VS OCF VS FCFJEN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

JEN's Return On Assets of 10.74% is amongst the best of the industry. JEN outperforms 91.26% of its industry peers.
JEN has a Return On Equity of 17.97%. This is amongst the best in the industry. JEN outperforms 84.47% of its industry peers.
JEN has a better Return On Invested Capital (13.79%) than 88.35% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for JEN is in line with the industry average of 8.77%.
The last Return On Invested Capital (13.79%) for JEN is above the 3 year average (9.39%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.74%
ROE 17.97%
ROIC 13.79%
ROA(3y)6.55%
ROA(5y)5.36%
ROE(3y)12.05%
ROE(5y)10.23%
ROIC(3y)9.39%
ROIC(5y)8.21%
JEN.BR Yearly ROA, ROE, ROICJEN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 10.63%, JEN belongs to the top of the industry, outperforming 86.41% of the companies in the same industry.
JEN's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 12.57%, JEN belongs to the top of the industry, outperforming 81.55% of the companies in the same industry.
In the last couple of years the Operating Margin of JEN has grown nicely.
JEN has a worse Gross Margin (14.50%) than 90.29% of its industry peers.
JEN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.57%
PM (TTM) 10.63%
GM 14.5%
OM growth 3Y8.87%
OM growth 5Y10.05%
PM growth 3Y17.42%
PM growth 5Y13.94%
GM growth 3Y8.28%
GM growth 5Y10.4%
JEN.BR Yearly Profit, Operating, Gross MarginsJEN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so JEN is creating value.
The number of shares outstanding for JEN has been reduced compared to 1 year ago.
JEN has more shares outstanding than it did 5 years ago.
JEN has a worse debt/assets ratio than last year.
JEN.BR Yearly Shares OutstandingJEN.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
JEN.BR Yearly Total Debt VS Total AssetsJEN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

JEN has an Altman-Z score of 4.22. This indicates that JEN is financially healthy and has little risk of bankruptcy at the moment.
JEN's Altman-Z score of 4.22 is amongst the best of the industry. JEN outperforms 86.41% of its industry peers.
JEN has a debt to FCF ratio of 1.11. This is a very positive value and a sign of high solvency as it would only need 1.11 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.11, JEN belongs to the top of the industry, outperforming 85.44% of the companies in the same industry.
JEN has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
JEN has a Debt to Equity ratio of 0.09. This is amongst the best in the industry. JEN outperforms 82.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.11
Altman-Z 4.22
ROIC/WACC1.87
WACC7.37%
JEN.BR Yearly LT Debt VS Equity VS FCFJEN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

A Current Ratio of 1.98 indicates that JEN should not have too much problems paying its short term obligations.
The Current ratio of JEN (1.98) is better than 72.82% of its industry peers.
A Quick Ratio of 1.49 indicates that JEN should not have too much problems paying its short term obligations.
JEN's Quick ratio of 1.49 is amongst the best of the industry. JEN outperforms 81.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.98
Quick Ratio 1.49
JEN.BR Yearly Current Assets VS Current LiabilitesJEN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. Growth

3.1 Past

JEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 46.32%, which is quite impressive.
JEN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.40% yearly.
The Revenue has grown by 16.22% in the past year. This is quite good.
The Revenue has been growing slightly by 6.41% on average over the past years.
EPS 1Y (TTM)46.32%
EPS 3Y32.2%
EPS 5Y16.4%
EPS Q2Q%51.85%
Revenue 1Y (TTM)16.22%
Revenue growth 3Y20.39%
Revenue growth 5Y6.41%
Sales Q2Q%15.76%

3.2 Future

JEN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.01% yearly.
Based on estimates for the next years, JEN will show a small growth in Revenue. The Revenue will grow by 3.68% on average per year.
EPS Next Y38.94%
EPS Next 2Y21.66%
EPS Next 3Y15.36%
EPS Next 5Y5.01%
Revenue Next Year16.78%
Revenue Next 2Y10.25%
Revenue Next 3Y7.64%
Revenue Next 5Y3.68%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
JEN.BR Yearly Revenue VS EstimatesJEN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M 500M
JEN.BR Yearly EPS VS EstimatesJEN.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.42 indicates a reasonable valuation of JEN.
Compared to the rest of the industry, the Price/Earnings ratio of JEN indicates a rather cheap valuation: JEN is cheaper than 83.50% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of JEN to the average of the S&P500 Index (27.20), we can say JEN is valued rather cheaply.
With a Price/Forward Earnings ratio of 9.29, the valuation of JEN can be described as very reasonable.
81.55% of the companies in the same industry are more expensive than JEN, based on the Price/Forward Earnings ratio.
JEN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.71.
Industry RankSector Rank
PE 11.42
Fwd PE 9.29
JEN.BR Price Earnings VS Forward Price EarningsJEN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

JEN's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, JEN is valued a bit cheaper than the industry average as 65.05% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 15.21
EV/EBITDA 8.71
JEN.BR Per share dataJEN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

JEN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of JEN may justify a higher PE ratio.
JEN's earnings are expected to grow with 15.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.29
PEG (5Y)0.7
EPS Next 2Y21.66%
EPS Next 3Y15.36%

3

5. Dividend

5.1 Amount

JEN has a Yearly Dividend Yield of 1.11%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.88, JEN has a dividend in line with its industry peers.
With a Dividend Yield of 1.11, JEN pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.11%

5.2 History

The dividend of JEN decreases each year by -5.10%.
Dividend Growth(5Y)-5.1%
Div Incr Years2
Div Non Decr Years4
JEN.BR Yearly Dividends per shareJEN.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

JEN pays out 18.67% of its income as dividend. This is a sustainable payout ratio.
DP18.67%
EPS Next 2Y21.66%
EPS Next 3Y15.36%
JEN.BR Yearly Income VS Free CF VS DividendJEN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M
JEN.BR Dividend Payout.JEN.BR Dividend Payout, showing the Payout Ratio.JEN.BR Dividend Payout.PayoutRetained Earnings

JENSEN-GROUP NV

EBR:JEN (9/16/2025, 7:00:00 PM)

62.8

-0.4 (-0.63%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-07 2025-08-07
Earnings (Next)11-05 2025-11-05
Inst Owners9.15%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap604.76M
Analysts80
Price Target63.24 (0.7%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.11%
Yearly Dividend0.77
Dividend Growth(5Y)-5.1%
DP18.67%
Div Incr Years2
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)15.89%
PT rev (3m)15.89%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)30.83%
EPS NY rev (3m)30.83%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.18%
Revenue NY rev (3m)3.41%
Valuation
Industry RankSector Rank
PE 11.42
Fwd PE 9.29
P/S 1.24
P/FCF 15.21
P/OCF 11.74
P/B 2.09
P/tB 2.55
EV/EBITDA 8.71
EPS(TTM)5.5
EY8.76%
EPS(NY)6.76
Fwd EY10.76%
FCF(TTM)4.13
FCFY6.58%
OCF(TTM)5.35
OCFY8.52%
SpS50.78
BVpS30.04
TBVpS24.59
PEG (NY)0.29
PEG (5Y)0.7
Profitability
Industry RankSector Rank
ROA 10.74%
ROE 17.97%
ROCE 18.35%
ROIC 13.79%
ROICexc 15%
ROICexgc 18.08%
OM 12.57%
PM (TTM) 10.63%
GM 14.5%
FCFM 8.13%
ROA(3y)6.55%
ROA(5y)5.36%
ROE(3y)12.05%
ROE(5y)10.23%
ROIC(3y)9.39%
ROIC(5y)8.21%
ROICexc(3y)11.13%
ROICexc(5y)10.46%
ROICexgc(3y)12.99%
ROICexgc(5y)12.14%
ROCE(3y)13.16%
ROCE(5y)11.32%
ROICexcg growth 3Y5.22%
ROICexcg growth 5Y2.88%
ROICexc growth 3Y5.28%
ROICexc growth 5Y0.03%
OM growth 3Y8.87%
OM growth 5Y10.05%
PM growth 3Y17.42%
PM growth 5Y13.94%
GM growth 3Y8.28%
GM growth 5Y10.4%
F-Score7
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.11
Debt/EBITDA 0.38
Cap/Depr 118.83%
Cap/Sales 2.41%
Interest Coverage 35.71
Cash Conversion 72.22%
Profit Quality 76.51%
Current Ratio 1.98
Quick Ratio 1.49
Altman-Z 4.22
F-Score7
WACC7.37%
ROIC/WACC1.87
Cap/Depr(3y)117.95%
Cap/Depr(5y)108.4%
Cap/Sales(3y)2.08%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)46.32%
EPS 3Y32.2%
EPS 5Y16.4%
EPS Q2Q%51.85%
EPS Next Y38.94%
EPS Next 2Y21.66%
EPS Next 3Y15.36%
EPS Next 5Y5.01%
Revenue 1Y (TTM)16.22%
Revenue growth 3Y20.39%
Revenue growth 5Y6.41%
Sales Q2Q%15.76%
Revenue Next Year16.78%
Revenue Next 2Y10.25%
Revenue Next 3Y7.64%
Revenue Next 5Y3.68%
EBIT growth 1Y36.81%
EBIT growth 3Y31.06%
EBIT growth 5Y17.1%
EBIT Next Year51.02%
EBIT Next 3Y17.26%
EBIT Next 5Y14.05%
FCF growth 1Y403.43%
FCF growth 3Y-6.22%
FCF growth 5Y1.6%
OCF growth 1Y765.39%
OCF growth 3Y-2.15%
OCF growth 5Y3.17%